Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
April 16, 2025
Multiple myeloma is treatable, not curable. Is that set to change?
Some experts believe a ‘functional cure’ is already within reach
37 years of nourishing care
Fred Hutch registered dietitian Paula Charuhas Macris reflects on changes and progress in patient care over the years
Donor factors influence success of fecal microbiota transplant
From the Rashidi Group, Pathogen Associated Malignancies Program of the Cancer Consortium and Clinical Research Division
Mutations remain one-in-a-million after HCT
From the Storb Group, Clinical Research Division
With Fred Hutch from the very start
Longtime supporters David and Deborah Lycette are more optimistic than ever that research will vanquish cancer
A charming model: new tool evaluates risk of transplant for older patients
Seven values are evaluated to predict outcomes
Infectious disease experts propose trials network dedicated to immunocompromised patients
ImmunOptimize workshop convened stakeholders across disciplines to brainstorm infectious disease clinical trials network designed to serve people with weakened immune systems
‘Black hole’ formed by aging cells hobbles key immune organ’s function, regeneration
Collaborative project reveals non-functional cells that accumulate in aging thymus
Fred Hutch’s new chief nursing officer says tragedy altered her perspective
Denene Prophet-Williams has a passion for solving problems while supporting patient care
Secret to tamping down GVHD may lie in microbial genetics
Preclinical bone marrow transplant study shows donor immune cells that target recipient microbiome can influence GVHD severity
Aplastic anemia diagnosis took business strategy manager by surprise
Transplant replaced his failing bone marrow with healthy cells
Pre-transplant microbiome sets the stage for GVHD
Preclinical findings highlight bacterial groups that influence GVHD risk
National study recommends starting SARS-CoV-2 mRNA vaccination three months after bone marrow transplant
Study involving 22 U.S. cancer centers and research institutions is one of the largest analyses of vaccination for any pathogen within the first year after bone marrow transplant
Year in Pictures: 2022
A look back at the year through compelling images
Depleting exhausted T cells enables memory T cells to be activated and fight blood cancer
From the Hill Lab, Clinical Research Division
Blood and Marrow Transplant Reunion returns to Fred Hutch
Hundreds gather in Seattle to celebrate life, science and cancer survivorship